Epidemiological and laboratory analysis of patients coinfected with HTLV-1 and HCV

Epidemiological and laboratory analysis of patients coinfected with HTLV-1 and HCV

Saved in:

Bibliographic Details
Main Author:	Alexandre Gomes Vizzoni
Format:	Article
Language:	English
Published:	Thieme Revinter Publicações 2010-12-01
Series:	Arquivos de Neuro-Psiquiatria
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2010000600030&lng=en&tlng=en
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Molecular epidemiology of HIV, HBV, HCV, and HTLV-1/2 in drug abuser inmates in central Javan prisons, Indonesia
by: Afiono Agung Prasetyo, et al.
Published: (2013-06-01)

Dried blood spot as alternative specimen for molecular epidemiology studies among HCV/HIV coinfected patients
by: Geane Flores, et al.
Published: (2025-03-01)

Prevalence and risk factor analysis for HIV/HTLV 1/2 coinfection in Paraíba state, Brazil
by: Marcela Santos de Souza, et al.
Published: (2021-10-01)

Tuberculous meningoencephalomyelitis and coinfection with HTLV-I + HTLV-II: case report Meningoencefalomielite tuberculosa e coinfecção por HTLV-I + HTLV-II: relato de caso
by: Marcio Menna-Barreto, et al.
Published: (2006-03-01)

Fatal Multiorgan Failure Syndrome in a Strongyloides-HTLV-1 Coinfected Patient, after Treatment with Ivermectin
by: Emmanuelle Guérin, et al.
Published: (2021-01-01)

Hospitalizations and deaths among people coinfected with HIV and HCV
by: Dorota Zarębska-Michaluk, et al.
Published: (2024-11-01)

Correction: Epidemiological Analysis of HTLV-1 and HTLV-2 Infection among Different Population in Central China
Published: (2013-01-01)

Ethnicity and Spontaneous Clearance of Hepatitis C in HIV-HCV Coinfected Patients
by: Lil Miedzinski, et al.
Published: (2008-01-01)

PBMCs gene expression predicts liver fibrosis regression after successful HCV therapy in HIV/HCV-coinfected patients
by: Ana Virseda-Berdices, et al.
Published: (2025-01-01)

Vitamin D and Osteoporosis in HIV/HCV Coinfected Patients: A Literature Review
by: Paola Di Carlo, et al.
Published: (2015-01-01)

Analytical and Biological Variables Influencing Quantitative Hepatitis C Virus (HCV) Measurement in HIV-HCV Coinfection
by: Curtis Cooper, et al.
Published: (2006-01-01)

Comparative analysis of the safety of triple therapy with telaprevir between HCV monoinfected and HIV coinfected patients
by: C. Sangrador Pelluz, et al.
Published: (2014-01-01)

Sustained Long-Term Decline in Anti-HCV Neutralizing Antibodies in HIV/HCV-Coinfected Patients Five Years after HCV Therapy: A Retrospective Study
by: Daniel Sepúlveda-Crespo, et al.
Published: (2024-08-01)

HIV, HBV and HCV Coinfection Prevalence in Iran--A Systematic Review and Meta-Analysis.
by: Fahimeh Bagheri Amiri, et al.
Published: (2016-01-01)

Effectiveness of Direct Antiviral Agents in People with HCV-Monoinfection Compared to HCV/HIV Coinfection in a Real Life Setting
by: Cristina Guadalupe Román López, et al.
Published: (2024-10-01)

Effectiveness of glecaprevir/pibrentasvir in HIV/HCV-coinfected patients treated with bictegravir/emtricitabine/tenofovir alafenamide
by: Aleksandra Berkan-Kawińska, et al.
Published: (2024-07-01)

Estimating an individual-level deprivation index for HIV/HCV coinfected persons in Canada.
by: Adam Palayew, et al.
Published: (2021-01-01)

Persistent Low Anti-HIV Neutralizing Antibody Titers in HIV/HCV Coinfection Despite HCV Cure: A 5-Year Longitudinal Analysis
by: Daniel Sepúlveda-Crespo, et al.
Published: (2025-05-01)

Functional exhaustion of CD4<sup>+</sup>T cells in HIV/HCV coinfected HAART-treated patients
by: V. V. Vlasova, et al.
Published: (2023-06-01)

Low plasma levels of BTLA and LAG-3 before HCV therapy are associated with metabolic disorders after HCV eradication in persons with HIV/HCV coinfection: a retrospective study
by: Rubén Martín-Escolano, et al.
Published: (2024-10-01)

Bystander Effects and Profibrotic Interactions in Hepatic Stellate Cells during HIV and HCV Coinfection
by: Cintia Cevallos, et al.
Published: (2024-01-01)

Modeling HTLV-1 and HTLV-2 co-infection dynamics
by: E. A. Almohaimeed, et al.
Published: (2025-03-01)

The experience of the Moscow City Center for AIDS Prevention and Treatment of using glecaprevir/pibrentasvir in patients with HIV/HCV coinfection
by: A. I. Mazus, et al.
Published: (2021-12-01)

Impact of HBV and HCV coinfection on CD4 cells among HIV-infected patients: a longitudinal retrospective study
by: Claudinei Mesquita da Silva, et al.
Published: (2018-11-01)

HTLV-1 is predominantly sexually transmitted in Salvador, the city with the highest HTLV-1 prevalence in Brazil.
by: David Nunes, et al.
Published: (2017-01-01)

Acute HCV/HIV coinfection is associated with cognitive dysfunction and cerebral metabolite disturbance, but not increased microglial cell activation.
by: Lucy J Garvey, et al.
Published: (2012-01-01)

Human T-Lymphotropic Virus (HTLV): Epidemiology, Genetic, Pathogenesis, and Future Challenges
by: Francesco Branda, et al.
Published: (2025-05-01)

HTLV-1 Infection and Cervicovaginal Susceptibility to High-Risk HPV: Findings from Women Living with HTLV-1 in Salvador, Brazil
by: Alisson de Aquino Firmino, et al.
Published: (2025-01-01)

HTLV-1 and HTLV-2 infections significantly alter small RNA expression in asymptomatic carriers
by: Lorena Abreu Fernandes, et al.
Published: (2025-02-01)

B‐cell depletion limits HTLV‐1‐infected T‐cell expansion and ameliorate HTLV‐1‐associated myelopathy
by: Aowei Lv, et al.
Published: (2024-10-01)

Key fungal coinfections: epidemiology, mechanisms of pathogenesis, and beyond
by: Danielle L. Silva, et al.
Published: (2025-05-01)

Correction for Taylor et al., “Depression in Individuals Coinfected with HIV and HCV Is Associated with Systematic Differences in the Gut Microbiome and Metabolome”
by: Bryn C. Taylor, et al.
Published: (2025-03-01)

Multicenter cross-sectional study of HTLV-1 prevalence and associated risk factors in epidemiologically relevant groups across Brazil
by: Carlos Brites, et al.
Published: (2025-03-01)

Mielopatias por HTLV-1 na cidade de Salvador, Bahia
by: Ailton Melo, et al.
Published: (1994-09-01)

Rheumatological Manifestations in People Living with Human T-Lymphotropic Viruses 1 and 2 (HTLV-1 and HTLV-2) in Northern Brazil
by: Márcio Yutaka Tsukimata, et al.
Published: (2025-06-01)

HTLV-1 and neurological conditions: when to suspect and when to order a diagnostic test for HTLV-1 infection? Doenças neurológicas e infecção pelo HTLV-1: quando suspeitar e quando solicitar testes diagnósticos para a infecção pelo HTLV-1
by: Abelardo Q.C. Araújo, et al.
Published: (2009-03-01)

COVID-19, HIV, and Cryptococcal Meningitis Coinfections with Abnormal Laboratory Findings
by: Mina Aghamali, et al.
Published: (2023-01-01)

Quantification of HTLV-1 clonality and TCR diversity.
by: Daniel J Laydon, et al.
Published: (2014-06-01)

Pulmonary involvement in patients with HTLV-I associated myelopathy Comprometimento pulmonar em pacientes com mielopatia associada ao HTLV-I
by: Kilma Mattos, et al.
Published: (1995-12-01)

Neurological symptoms and signs in HTLV-1 patients with overactive bladder syndrome
by: Davi Tanajura Costa, et al.
Published: (2012-04-01)